The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Altuvoct (efanesoctocog alfa) to be used to ...

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A: United Kingdom Monday, February 17, 2025, ...

Chidimma Adetshina's mother, Rungo, has been reportedly arrested in Cape Town over alleged illegal residence in South Africa. Discover: ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Shares of Swedish Orphan Biovitrum AB (STO:SOBI) fell 3% as the company's fourth-quarter earnings report revealed mixed results. While overall Q4 revenue met consensus expectations, sales of its key ...

Just as fashion trends go out of style (we’re looking at you, shoulder pads and leg warmers), once-popular baby names also fade from glory. Of course, it’s easy to understand how it can happen ...

In recent years, we've seen some unusual baby names spiral in popularity, whether that's a name after a season or one that is a little trickier to pronounce - but this year, traditional names are ...

Sobi plans to publish its report for the fourth quarter and full year of 2024 on 5 February 2025 at 08:00 CET. STOCKHOLM, Jan. 21, 2025 /PRNewswire/ -- Investors, analysts, and the media are ...